NYSE Content Update: Alto Neuroscience Raises $120 Million to Fund Development of ALTO-207

Alto Neuroscience will discuss a $120 million private placement to advance development of its psychiatric candidate ALTO-207 on NYSE Live on March 23, 2026.

Rhea-AI Summary

Alto Neuroscience will discuss a $120 million private placement to advance development of its psychiatric candidate ALTO-207 on NYSE Live on March 23, 2026. Nick Smith, Alto CFO, will appear on NYSE Live to explain the financing and its intended use.

The NYSE pre-market update for March 23, 2026 also covers market movement after postponed strikes on Iran, an AI-at-work KPMG survey, RSAC conference coverage, and corporate notes including Copa Airlines (NYSE: CPA) and Jacobs (NYSE: J).

Positive

• $120 million private placement to fund ALTO-207 development
• CFO media appearance on NYSE Live increases investor visibility

Negative

• None.

Argus Mar 23 session

-0.80% close to close Open Argus

Details

News Market Reaction – ICE

On Mar 23, the day this news came out, ICE closed 0.80% below the previous close.

Data tracked by StockTitan Argus for the Mar 23 session.

Key Figures

Net revenues: $9.9 billion GAAP diluted EPS: $5.77 Adjusted diluted EPS: $6.95 +5 more

Net revenues

$9.9 billion

2025 highlights from PRE 14A filing

GAAP diluted EPS

$5.77

2025 highlights from PRE 14A filing

Adjusted diluted EPS

$6.95

2025 highlights; up 14% year-over-year

EPS growth

14%

Adjusted diluted EPS year-over-year increase in 2025

Capital returned

$2.4 billion

2025 buybacks and dividends to stockholders

Private placement

$120 million

Alto Neuroscience financing highlighted in NYSE content update

Share price

$158.43

ICE pre-news current price

Volume today

4,165,870 shares

Compared with 20-day average volume of 3,703,624

Historical Context

5 past events · Latest: Mar 19

5 events

1. Mar 19

   NYSE content update

   24h Move

   +0.8%

   NYSE content featuring Xylem and World Water Day initiatives.

2. Mar 18

   Annual meeting notice

   24h Move

   +0.8%

   Announcement of 2026 virtual annual stockholder meeting details.

3. Mar 18

   AI platform preview

   24h Move

   -2.3%

   NYSE pre-market update highlighting Snowflake AI platform and Fed preview.

4. Mar 17

   AI product launch

   24h Move

   -0.4%

   Launch of AI voice and chat agents for mortgage servicing at ICE event.

5. Mar 17

   NYSE content update

   24h Move

   -0.4%

   NYSE update featuring Diageo bell-ringing and VENU capital raise.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

private placement financing

1 terms

private placement financing financial

"Alto Neuroscience CFO Nick Smith will join NYSE Live to discuss the company's $120 million in private placement financing"

Private placement financing is when a company raises money by selling stocks, bonds or other securities directly to a small group of chosen investors instead of offering them on the public market. For investors it matters because these deals can change ownership stakes, bring fresh cash for growth or debt reduction, and affect how easy it is to buy or sell those securities later—think of it like inviting a few private backers into a business rather than opening the door to the whole neighborhood.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NYSE issues a pre-market daily advisory direct from the trading floor.

NEW YORK, March 23, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

Ashley Mastronardi delivers the pre-market update on March 23^rd

• Stocks jump and oil retreats after President Donald Trump postpones strikes on Iran energy targets with ceasefire talks beginning.
• Alto Neuroscience CFO Nick Smith will join NYSE Live to discuss the company's $120 million in private placement financing to help advance its mission of matching patients with the right psychiatric medications.
• An executive from KPMG will join NYSE Live to share the results of a new survey that looks at how employees are using AI in the workplace.
• The RSAC Conference, focusing on cybersecurity innovation and AI-driven defense, kicks off today from San Francisco.

For market insights, IPO activity, and today's opening bell, download the NYSE TV app at tv.nyse.com

Opening Bell
Copa Airlines (NYSE: CPA) celebrates 20^th listing anniversary.

Closing Bell
Jacobs (NYSE: J) hosts global executive leadership team meeting for 180 leaders in Midtown and visiting the NYSE.

Click here to download the NYSE TV App

View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-update-alto-neuroscience-raises-120-million-to-fund-development-of-alto-207-302722038.html

SOURCE New York Stock Exchange

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Alto Neuroscience announce about the $120 million financing on March 23, 2026?

Alto Neuroscience announced a $120 million private placement to advance ALTO-207 development. According to Alto Neuroscience, the financing is intended to help match patients with appropriate psychiatric medications and support clinical development activities.

When will Alto Neuroscience CFO Nick Smith appear on NYSE Live to discuss the financing?

Nick Smith will join NYSE Live on March 23, 2026 to discuss the private placement. According to Alto Neuroscience, the appearance will cover the use of proceeds and how financing supports ALTO-207 development plans.

How does the $120 million private placement affect Alto Neuroscience's development of ALTO-207?

The financing is intended to fund advancement of ALTO-207 in psychiatric drug development. According to Alto Neuroscience, proceeds will be used to accelerate clinical and development activities tied to matching patients to medications.

Where can investors watch the Alto Neuroscience discussion on NYSE Live on March 23, 2026?

Investors can view the segment on NYSE Live / NYSE TV on March 23, 2026. According to NYSE, the pre-market update and live interviews are available via the NYSE TV app and website.

Did the March 23, 2026 NYSE pre-market update include other market news affecting NYSE: J?

Yes, the pre-market update covered wider market moves and corporate notes including Jacobs (NYSE: J) hosting a global leadership meeting. According to NYSE, the update also mentioned market reactions and conference coverage.

What investor information did the NYSE pre-market update provide on March 23, 2026?

The NYSE pre-market update provided market context, corporate appearances, and event coverage for March 23, 2026. According to NYSE, it included trading-floor insights, company interviews, IPO activity, and opening bell information.